arsenic has been researched along with Experimental Radiation Injuries in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, H; Knox, SJ; Li, X; Peehl, DM; Saar, M; Santos, J; Tian, J | 1 |
| Ganapathy, S; Ha, CS; Li, X; Su, H; Yuan, ZM | 1 |
| Immich, H; Jung, EG; Traschel, B | 1 |
3 other study(ies) available for arsenic and Experimental Radiation Injuries
| Article | Year |
|---|---|
Radioprotection and cell cycle arrest of intestinal epithelial cells by darinaparsin, a tumor radiosensitizer.
Topics: Animals; Apoptosis; Arsenicals; Cell Cycle Checkpoints; DNA Damage; DNA Repair; Duodenum; Epithelial Cells; Female; Gastrointestinal Tract; Glutathione; Heterografts; Humans; Male; Mice; Prostatic Neoplasms; Radiation Injuries, Experimental; Radiation Tolerance; Radiation-Protective Agents; Radiation-Sensitizing Agents; Syndrome | 2013 |
p53-Based Strategy for Protection of Bone Marrow From Y-90 Ibritumomab Tiuxetan.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Arsenic; Biomarkers; Bone Marrow; Bone Marrow Cells; DNA Damage; Female; Genes, p53; Glucose Transporter Type 1; Glucose Transporter Type 3; Heterografts; Histones; In Situ Nick-End Labeling; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Radiation Dosage; Radiation Injuries, Experimental; Radiation Tolerance; Radiation-Protective Agents; Radioimmunotherapy; Transcriptional Activation; Yttrium Radioisotopes | 2015 |
Arsenic as an inhibitor of the enzymes concerned in cellular recovery (dark repair).
Topics: Adult; Animals; Arsenic; Autoradiography; Cell Transformation, Neoplastic; Enzyme Repression; Humans; In Vitro Techniques; Male; Radiation Injuries, Experimental; Skin; Skin Neoplasms; Skin Transplantation; Transplantation, Homologous; Tritium | 1969 |